With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.56100-22-2,6-Methyl-2,2′-bipyridine,as a common compound, the synthetic route is as follows.
To a 20 mL methanolic solution of UO2(NO3)2.6H2O(0.12 g, 0.25 mmol), 20 mL methanolic solution of 6-methylbipyridine (3.29 mL,0.25 mmol) was added. The resulting solution was stirred at 55-60C for 2 h. The solid (desired product) was collected by suction filtration, washed with acetone, then air dried. The product dissolved in a mixture of CH3CN/CH3OH and then left to evaporated slowly at room temperature. After 10 days, yellow block crystals were isolated (yield 72%, m.p. >300). IR (KBr, cm1): 3421 n(NH), 3114n(CHcycle),2910n(CHMe), 1622 n(NO), 1487-1304n(CHC) andn(CHN), 1279 n(ONO), 929 ns(OUO), 777nas(OUO).[11,12]Anal. Calcd.: C, 22.69; H, 2.06; N,9.62. Found: C, 22.47; H, 2.04; N, 9.54.
The synthetic route of 56100-22-2 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Saravani, Hamideh; Mozafaripoor, Farima; Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry; vol. 45; 11; (2015); p. 1717 – 1722;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI